Intralesional Botulinum Toxin Type A Injection as a New Treatment Measure for Keloids
- 1 November 2009
- journal article
- research article
- Published by Ovid Technologies (Wolters Kluwer Health) in Plastic and Reconstructive Surgery
- Vol. 124 (5), 275e-277e
- https://doi.org/10.1097/prs.0b013e3181b98ee7
Abstract
No abstract availableThis publication has 6 references indexed in Scilit:
- Essential Role of IL-6 Signaling Pathway in Keloid PathogenesisJournal of Nippon Medical School, 2007
- Novel Action of Botulinum Toxin on the Stromal and Epithelial Components of the Prostate GlandJournal of Urology, 2006
- Combined Therapy in the Treatment of Auricular KeloidsEar, Nose & Throat Journal, 2006
- Postsurgical Use of Imiquimod 5% Cream in the Prevention of Earlobe Keloid Recurrences: Results of an Open-Label, Pilot StudyDermatologic Surgery, 2005
- INTRAVESICAL BOTULINUM TOXIN A ADMINISTRATION PRODUCES ANALGESIA AGAINST ACETIC ACID INDUCED BLADDER PAIN RESPONSES IN RATSJournal of Urology, 2004
- Botulinum toxin type A: History and current cosmetic use in the upper faceSeminars in Cutaneous Medicine and Surgery, 2001